SUFICS-PACT for Cancer Survivors

Overseen by Nnenaya A. Mmonu, MD, MS

Age: 18+

Sex: Male

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: NYU Langone Health

No Placebo Group

Trial Summary

What is the purpose of this trial?

The purpose of this study is to test the efficacy of SUFICS-PACT to identify and treat sexual and urinary dysfunction in prostate cancer survivors at NYC H+ H/Bellevue, the oldest public hospital in the US. This study will evaluate the implementation of an adapted sexual and urinary function collaborative care model at NYC Health+Hospitals/Bellevue. The study will test the efficacy of this collaborative care model through a randomized controlled trial in the adult primary care clinic; the intervention arm will receive collaborative treatment consisting of a care manager who has specialty training in mental health and psychosexual counseling, a primary care nurse practitioner who leads symptom management, primary care physicians who supervise the team, and a team specialty consult liaison.

Research Team

Nnenaya A. Mmonu, MD, MS

Principal Investigator

NYU Langone Health

Eligibility Criteria

This trial is for prostate cancer survivors experiencing sexual or urinary dysfunction. Participants will be treated at NYC Health+Hospitals/Bellevue and must be willing to undergo a collaborative care model treatment. Specific eligibility criteria are not provided, but typically include factors like age, health status, and previous treatments.

Inclusion Criteria

I have been diagnosed with prostate cancer.

I am 18 years old or older.

I have sought treatment for prostate cancer.

Exclusion Criteria

I am under 18 years old.

Patients who are categorized as 'vulnerable subjects' such as minors or incarcerated individuals.

I have not sought treatment for prostate cancer.

Treatment Details

Interventions

• SUFICS-PACT (Behavioral Intervention)

Trial Overview The study tests the SUFICS-PACT program's effectiveness in treating sexual and urinary dysfunctions in prostate cancer survivors using a team approach. This includes specialty-trained care managers, nurse practitioners, physicians, and consult liaisons working together.

Participant Groups

Group I: SUFICS-PACT Experimental Treatment 1 Intervention

The Sexual and Urinary Function Improvement for Cancer Survivors- Promoting Access to Collaborative Treatment (SUFICS-PACT) intervention integrates a collaborative care model in primary care to facilitate problem identification, comprehensive treatment, and close follow-up for sexual and urinary dysfunction.

Group II: Usual care Active Control 1 Intervention

Participants assigned to this group will continue with usual care.

Who Is Running the Clinical Trial?

NYU Langone Health

Lead Sponsor

Trials

1,431

Recruited

838,000+

Dr. Alec C. Kimmelman

NYU Langone Health

Chief Executive Officer

MD and PhD from Mount Sinai School of Medicine

Dr. Nicole M. Adler

NYU Langone Health

Chief Medical Officer since 2023

MD